Useful links
  /  Publications 

Publications

2023

RII authors are marked with an asterisk(*); — indexed by Scopus; — indexed by Web of Science.

Research papers:

  1. 5-(Perylen-3-ylethynyl)uracil as an antiviral scaffold: Potent suppression of enveloped virus reproduction by 3-methyl derivatives in vitro
    Chistov A.A., Chumakov S.P., Mikhnovets I.E., Nikitin T.D., Slesarchuk N.A., Uvarova V.I., Rubekina A.A., Nikolaeva* Yu.V., Radchenko E.V., Khvatov E.V., Orlov A.A., Frolenko V.S., Sukhorukov M.V., Kolpakova E.S., Shustova E.Y., Galochkina* A.V., Streshnev Ph.P., Osipov E.M., Sapozhnikova K.A., Moiseenko A.V., Brylev V.A., Proskurin G.V., Dokukin Yu.S., Kutyakov S.V., Aralov A.V., Korshun V.A., Strelkov S.V., Palyulin V.A., Ishmukhametov A.A., Shirshin E.A., Osolodkin D.I., Shtro* A.A., Kozlovskaya L.I., Alferova V.A., Ustinov A.V.
    Antiviral Research — 2023. — Vol. 209. — Issue. . — pp. 105508-
    DOI: 10.1016/j.antiviral.2022.105508
  2. A Genome of Temperate Enterococcus Bacteriophage Placed in a Space of Pooled Viral Dark Matter Sequences
    Pchelin I.M., Tkachev P.V., Azarov D.V., Gorshkov* A.N., Drachko D.O., Zlatogursky V.V., Dmitriev A.V., Goncharo A.E.
    Viruses — 2023. — Vol. 15. — Issue. 1. — pp. 216-
    DOI: 10.3390/v15010216
  3. Comparative Study of the Myocardium of Patients from Four COVID-19 Waves
    Mitrofanova L.B., Makarov I.A., Gorshkov* A.N., Runov A.L., Vonsky M.S., Pisareva* M.M., Komissarov* A.B., Makarova T.A., Li Q., Karonova T.L., Konradi A.O., Shlaykhto E.V.
    Diagnostics — 2023. — Vol. 13. — Issue. 9. — pp. 1645-
    DOI: 10.3390/diagnostics13091645
  4. COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report
    Belozerov K.E., Avrusin I.S., Andaryanova L.I., Guseva A.M., Shogenova Z.S., Belanovich I.N., Lobacheva A.V., Kornishina T.L., Isupova E.A., Masalova V.V., Kalashnikova O.V., Nokhrin A.V., Panova T.F., Dutova Yu.P., Myshkovskaya S.L., Kostyunin K.Y., Komissarov* A.B., Chasnyk V.G., Bregel L.V., Kostik M.M.
    Biomedicines — 2023. — Vol. 11. — Issue. 3. — pp. 870-
    DOI: 10.3390/biomedicines11030870
  5. Evaluation of the immunotoxicity and allergenicity of a new intranasal influenza vector vaccine against tuberculosis carrying TB10.4 and HspX antigens
    Stosman* K.I., Aleksandrov* A.G., Sivak* K.V., Buzitskaya* Z.V., Stukova* M.A.
    Iranian Journal of Basic Medical Sciences — 2023. — Vol. 26. — Issue. 5. — pp. 558-563
    DOI: 10.22038/IJBMS.2023.68440.14936
  6. Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
    Lioznov* D.A., Amosova* I.V., Sheetikov S.A., Zornikova K.V., Serdyuk Y., Efimov G.A., Tsyferov M., Khmelevskii M., Afanasiev A., Khomyakova N., Zubkov D. Tikhonov A., Zhu T., Barreto L., Dzutseva V.
    PLoS ONE — 2023. — Vol. 18. — Issue. 3. — pp. e0278878-
    DOI: 10.1371/journal.pone.0278878
  7. Inside and outside of virus-like particles HBc and HBc/4M2e: A comprehensive study of the structure
    Egorov* V.V., Shvetsov A.V., Pichkur E.B., Shaldzhyan* A.A., Zabrodskaya* Ya.A., Vinogradova D.S., Nekrasov* P.A., Gorshkov* A.N., Garmay Yu.P., Kovaleva* A.A., Stepanova* L.A., Tsybalova* L.M., Shtam T.A., Myasnikov A.G., Konevega A.L.
    Biophysical Chemistry — 2023. — Vol. 293. — Issue. . — pp. 106943-
    DOI: 10.1016/j.bpc.2022.106943
  8. Peptide from NSP7 is able to form amyloid-like fibrils: Artifact or challenge to drug design?
    Garmay Y., Rubel A., Egorov* V.
    Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics — 2023. — Vol. 1871. — Issue. 2. — pp. 140884-
    DOI: 10.1016/j.bbapap.2022.140884
  9. Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis
    Shurygina* A.-P., Zabolotnykh N., Vinogradova T., Khairullin B., Kassenov M., Nurpeisova A., Sarsenbayeva G., Sansyzbay A., Vasilyev* K., Buzitskaya* J., Egorov* A., Stukova* M.
    — 2023. — Vol. 24. — Issue. 8. — pp. 7439-
    DOI: 10.3390/ijms24087439
  10. Reorganization and Suppression of Store-Operated Calcium Entry in Podocytes of Type 2 Diabetic Rats
    Gusev K., Shalygin A., Kolesnikov D., Shuyskiy L., Makeenok S., Glushankova L., Sivak* K., Yakovlev* K., Orshanskaya* Y., Wang G., Bakhtyukov A., Derkach K., Shpakov A., Kaznacheyeva E.
    International Journal of Molecular Sciences — 2023. — Vol. 24. — Issue. 8. — pp. 7259-
    DOI: 10.3390/ijms24087259
  11. Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020
    Williams T., Jackson S., Barr I., Bi S., Bhiman J., Ellis J., von Gottberg A., Lindstrom S., Peret T., Rughooputh S., Viegas V., Hirve S., Zambon V., Zhang W., WHO RSV Surveillance Group (Dakhilalla A., …, Pisareva* M., …, Deng Y. M.)
    Influenza and Other Respiratory Viruses — 2023. — Vol. 17. — Issue. 1. — pp. e13073-
    DOI: 10.1111/irv.13073
  12. Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
    Kudriavtsev A.V., Vakhrusheva A. V., Kryuchkov N.A., Frolova M. E., Blagodatskikh K.A., Ivanishin T. V., Djonovic M., Romanovskaya-Romanko* E.A., Kovalenko A.N., Lioznov* D.A., Zubkova* T.G., Teplykh S.V., Oseshnyuk R.A., Stukova* M.A., Krasilnikov* I.V.
    Vaccines — 2023. — Vol. 11. — Issue. 2. — pp. 326-
    DOI: 10.3390/vaccines11020326
  13. SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19
    Stanevich* O.V., Alekseeva E.I., Sergeeva* M.V., Fadeev* A.V., Komissarova* K.S., Ivanova* A.A., Simakova T.S., Vasilyev* K.A., Shurygina* A.P., Stukova* M.A., Safina K.R., Nabieva E.R., Garushyants S.K., Klink G.V., Bakin E.A., Zabutova J.V., Kholodnaia A.N., Lukina O.V., Skorokhod I.A., Ryabchikova V.V., Medvedeva N.V., Lioznov* D.A., Danilenko* D.M., Chudakov D.M., Komissarov* A.B., Bazykin G.A.
    Nature Communications — 2023. — Vol. 14. — Issue. . — pp. 149-
    DOI: 10.1038/s41467-022-34033-x
  14. Structural and Immunoreactivity Properties of the SARS-CoV-2 Spike Protein upon the Development of an Inactivated Vaccine
    Kordyukova L.V. , Moiseenko A.V., Serebryakova M.V., Shuklina* M.A., Sergeeva* M.V., Lioznov* D.A., Shanko A.V.
    Viruses — 2023. — Vol. 15. — Issue. 2. — pp. 480-
    DOI: 10.3390/v15020480
  15. Uncertainty Estimation for Quantitative Agarose Gel Electrophoresis of Nucleic Acids
    Semenov K., Taraskin* A., Yurchenko A., Baranovskaya I., Purvinsh L., Gyulikhandanova* N., Vasin* A.
    Sensors — 2023. — Vol. 23. — Issue. 4. — pp. 1999-
    DOI: 10.3390/s23041999
  16. Virological and Genetic Characterization of the Unusual Avian Influenza H14Nx Viruses in the Northern Asia
    Dubovitskiy N., Derko A., Sobolev I., Prokopyeva E., Murashkina T., Solomatina M., Kurskaya O., Komissarov* A., Fadeev* A., Danilenko* D., Petrova* P., Mine J., Tsunekuni R., Uchida Y., Saito T., Shestopalov A., Sharshov K.
    Viruses — 2023. — Vol. 15. — Issue. 3. — pp. 734-
    DOI: 10.3390/v15030734

2022 and older